期刊文献+

血浆生长分化因子-15水平检测对左心衰竭的临床意义 被引量:7

Clinical significance of plasma growth differentiation factor-15 in patients with left heart failure
原文传递
导出
摘要 目的:通过检测生长分化因子-15(GDF-15)血浆水平来探讨其与左侧心力衰竭(心衰)的关系,并与脑钠肽(BNP)比较其在左心衰诊断中的价值。方法:入选左心衰患者110例和正常人36例。ELISA检测血浆GDF-15水平。结果:左心衰组血浆GDF-15水平较对照组明显升高[2 368.65(1 493.96,3 859.89)ng/L∶1 090.80(892.59,1 749.35)ng/L,P<0.01],且随着NYHA程度的加重而增加。相关分析显示,GDF-15分别与NYHA分级(r=0.567,P=0.00)、左室舒张末径(r=0.209,P=0.030)、左室射血分数(r=-0.226,P=0.019)、BNP(r=0.223,P=0.020)有相关性。多元线性回归分析中,仅有NYHA分级(标化的相关系数B=0.576,P=0.000)与GDF-15密切相关。ROC曲线分析表明,GDF-15与BNP均可用于诊断慢性心衰。结论:GDF-15是良好心衰标志物,可作为辅助诊断左心衰的指标。 Objective:Through assessing relationship between plasma GDF-15 levels and left heart failure(HF),to explore the diagnosis value of plasma GDF-15 in HF patients.Method:There were 110 patients with HF and 36 normal controls were recruited for this study.Based on causes,they were classified as ischemic heart failure group(IHF,n=69) and non-ischemic heart failure group(NIHF,n=41);Further,based on left ventricular ejection function,they were divided into heart failure with the left ventricular ejection fraction(LVEF) ≤45%(n=29) and heart failure with the LVEF45%(n=81).GDF-15 levels were measured by ELISA.Result:Plasma concentration of GDF-15 was significantly higher in HF group than in control [2 368.65(1 493.96,3 859.89)ng/L∶1 090.80(892.59,1 749.35)ng/L,P0.01],and it was gradually increased depending on NYHA functional class.Multivariate stepwise regression analysis showed that only NYHA classification(B=0.576,P=0.000) has close relationship with GDF-15.Further,ROC curves analysis showed that both GDF-15 and BNF could be used for HF diagnosis.Conclusion:Compare with BNP,GDF-15 may serve as a good biomarker for the diagnosis of HF.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2012年第4期252-255,共4页 Journal of Clinical Cardiology
基金 广东省科技计划项目(No:2008A030201023)
关键词 心力衰竭 生长分化因子-15 脑钠肽 heart failure GDF-15 BNP
  • 相关文献

参考文献8

  • 1ANAND I S,KEMPF T,RECTOR T S,et al.Serial measurement of growth-differentiation afactor-15in heart failure:relation to disease severity and prognosis in the Valsartan Heart Failure Trial[].Circulation.2010 被引量:1
  • 2KEMPF T,BJORKLUND E,OLOFSSON S,et al.Growth-differentiation factor-15improves risk strati-fication in ST-segment elevation myocardial infarction[].European Heart Journal.2007 被引量:1
  • 3Hogg K,Swedberg K,McMurray J.Heart Failure With Preserved Left Ventricular Systolic Function: Epidemiology, Clinical Characteristics, and Prognosis[].Journal of the American College of Cardiology.2004 被引量:1
  • 4K.C. Wollert,T. Kempf,T. Peter.Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome[].Circulation.2007 被引量:1
  • 5T. Kempf,S. Haehling,T. Peter.Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure[].Journal of the American College of Cardiology.2007 被引量:1
  • 6Zimmers TA,Jin X,Hsiao EC,McGrath SA,EsquelaAF,Koniaris LG.Growth differentiation factor-15/macrophage inhibitory cytokine-1induction after kidney and lung injury[].Shock.2005 被引量:1
  • 7Xu J,Kimball TR,Lorenz JN,et al.GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation[].Circulation Research.2006 被引量:1
  • 8Tibor Kempf,Matthias Eden,Jens Strelau,Marian Naguib,Christian Willenbockel,Jorn Tongers,Jorg Heineke,Daniel Kotlarz,Jian Xu,Jeffery D. Molkentin,Hans W. Niessen,Helmut Drexler,Kai C. Wollert.The Transforming Growth Factor-β Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury[].Circulation Research.2006 被引量:1

同被引文献74

  • 1陈莉莉,郭小梅,杨霏.Role of Heart-Type Fatty Acid Binding Protein in Early Detection of Acute Myocardial Infarction in Comparison with cTnI, CK-MB and Myoglobin[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2004,24(5):449-451. 被引量:33
  • 2王晓健,惠汝太.一个新的保护心脏TGF-β超家族成员——GDF15[J].中国分子心脏病学杂志,2006,6(4):242-245. 被引量:5
  • 3李金英,许恒忠.卡维地洛的药理作用与临床应用[J].实用医技杂志,2006,13(19):3420-3421. 被引量:4
  • 4李立和(综述),涂植光(审校).缺血修饰清蛋白的研究进展[J].国际检验医学杂志,2007,28(1):62-63. 被引量:2
  • 5Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure):developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:endorsed by the Heart Rhythm Society[J].Circulation,2005,112(12):e154-e235. 被引量:1
  • 6Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC(HFA)and endorsed by the European Society of Intensive Care Medicine(ESICM)[J].Eur Heart J,2008,29(19):2388-2442. 被引量:1
  • 7Dinh W,Füth R,Lankisch M,et al.Growth-differentiation factor-15:a novel biomarker in patients with diastolic dysfunction?[J].Arq Bras Cardiol,2011,97(1):65-75. 被引量:1
  • 8Bootcov MR,Bauskin AR,Valenzuela SM,et al.MIC-1,a novel macrophage inhibitory cytokine,is a divergent member of the TGF-beta superfamily[J].Proc Natl Acad Sci U S A,1997,94(21):11514-11519. 被引量:1
  • 9Wollert KC,Kempf T.Growth differentiation factor 15 in heart failure:an update[J].Curr Heart Fail Rep,2012,9(4):337-345. 被引量:1
  • 10Kempf T,von Haehling S,Peter T,et al.Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure[J].J Am Coll Cardiol,2007,50(11):1054-1060. 被引量:1

引证文献7

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部